相关实验视频

Updated: Sep 16, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

[基于风险评估的辅助剂环境中的激素治疗]

Julie Cabal¹, Céline Lescure¹, Véronique Dieras¹

¹CLCC Eugène-Marquis, Rennes, France.

Bulletin du cancer

|July 5, 2025

概括

早期HR+乳腺癌的辅助激素治疗取决于复发风险. 高风险患者可能会从强化治疗中受益,包括卵巢抑制,以奥林匹亚,monarchE和NATALEE等研究为指导.

科学领域:

在瘤学瘤学.
内分泌学在内分泌学.
遗传学是一个遗传学.

背景情况:

辅助激素治疗对于早期激素受体阳性 (HR+) 乳腺癌至关重要.
对复发的风险评估是个性化治疗策略的关键.
在低风险的瘤中,通过标准激素治疗,可以缓解治疗的升级.

研究的目的:

审查关于延长激素治疗与卵巢抑制的当前问题.
讨论管理HR+乳腺癌复发风险的当代策略.
突出指导治疗决策的关键临床研究.

主要方法:

审查最近的临床问题和治疗策略.
专注于临床试验,包括奥林匹亚,monarchE和NATALEE.
对乳腺癌辅助治疗风险分层的分析.

主要成果:

标准激素治疗适用于低风险HR+乳腺癌.
高风险或中等风险的瘤需要加强治疗方法.
临床研究正在积极塑造对延长激素治疗和卵巢抑制的决策.

结论:

个性化风险评估对于HR+乳腺癌管理至关重要.
强化辅助策略,包括向治疗和卵巢抑制,适用于高风险患者.
目前正在进行的研究和临床试验继续改进激素治疗方案.

关键词:

辅助性激素治疗是一种辅助性激素治疗.生物标志物生物标志物生物标志物生物标志物乳腺癌是RH++的乳腺癌 HR+ 乳腺癌的治疗方法荷尔蒙疗法的辅助疗法风险分层是指风险的分层.风险分层的分层化有针对性的治疗方法.有针对性的疗法.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

相关概念视频

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Hormones of the Adrenal Glands

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.